instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: Gov. Brian Kemp said proposed changes to former President Barack Obama's Affordable Care Act would give individuals and families less expensive coverage options, a particular benefit for those who don't qualify for federal subsidies to cover premiums. "They're going to work to reduce costs, make health care more accessible and have better quality in our state," Kemp said in a statement. Critics say it would drive up insurance costs for older and sicker people. Kemp also wants to offer subsidized coverage to a fraction of Georgia's uninsured poor if they worked or went to school for 80 or more hours a month. Kemp's administration projects the expansion would cover 50,000 people, far less than the 400,000 uninsured Georgians who might be covered by the Medicaid expansion originally envisioned by the overhaul. This second proposal, aimed at people earning incomes of up to 100% of the federal poverty level, echoes those made by other states. Federal officials have rejected some similar partial expansions. But it's the first plan, under which Georgia would take over the federal insurance marketplace and the associated funding that goes with it, that's drawing national notice. The state would make those federal subsidies available to people who buy health plans that don't provide the full array of benefits that the Affordable Care Act requires. Passed in 2010, Obama's signature health care law extended insurance coverage to millions of Americans by expanding Medicaid and subsidizing premiums for individuals and families who make up to four times the federal poverty level. The law also known as "Obamacare" allows states to seek waivers from the federal government to change certain provisions, but only if they adhere to strict rules. The Trump administration has loosened those rules, and Kemp's plan includes three approaches promoted by the federal Centers for Medicare and Medicaid Services in November 2018. Health policy experts say that change would drive up ACA premiums by drawing healthier people to less expensive, skimpier insurance plans. That would leave the ACA with a sicker patient pool. Under Kemp's plan, Georgia residents would be required to bypass the central HealthCare.gov website to sign up for insurance. Instead, the state would redirect them to a list of approved brokers and insurers where consumers would be able to compare ACA-compliant plans side by side with plans that don't meet ACA requirements. All plans would have to continue covering preexisting conditions. In addition to the current gold, silver and bronze level plans, Georgia would let insurers offer a new lower tier of benefits, called copper level, which would cover only about half the cost of projected expenses. The current lowest level of bronze covers about 60% of costs. The state says copper level premiums are expected to be 17% lower than bronze level premiums, on average. Georgia also would let insurers offer disease management plans aimed at helping patients manage a particular high-cost disease such as diabetes or HIV and AIDS. State officials would set an overall cap on its own subsidies at $255 million. There is no cap under the ACA, although the state doesn't project its spending will come anywhere near the cap, even though it projects enrollment will increase by more than 37,000. The governor's office estimates that the availability of subsidies for pared-down health plans would only increase "Obamacare" premiums by a little more than 1%. State officials say that amount would be more than offset by its intention to pay a portion of insurance companies' costs to treat their sickest patients, a relatively small group that incurs the biggest bills. The so-called reinsurance program would allow the companies to lower monthly premiums for all customers. Twelve other states have received approval for reinsurance programs, according to data from the Kaiser Family Foundation. State officials expect to hear by August whether Georgia has permission to implement its plans. Claim: Georgia's Kemp submits bid to remake health insurance market.
answer:
Georgia's Republican governor on Monday submitted twin plans requesting that President Donald Trump's administration allow changes to federal government subsidies for health insurance.

question:
Paragraph: "Independents need to know they can invest their vote in the Democratic Party," Carter said Tuesday during his annual report at his post-presidential center and library in Atlanta, where he offered caution about the political consequences should Democrats "move to a very liberal program, like universal health care." That's delicate and, Carter admitted, even contradictory advice coming from the 93-year-old former president, and it underscores the complicated political calculations for Democrats as they prepare for the November midterms and look ahead to the 2020 presidential election. "Rosie and I voted for Bernie Sanders in the past," Carter noted. He was referring to his wife, Rosalynn, and their support for the Vermont senator, an independent who identifies as a democratic socialist, over establishment favorite Hillary Clinton in the 2016 Democratic presidential primary. At another point, he pointed to California's environmental policies limits on carbon emissions, stiffer fuel-efficiency standards as the model for combating climate change. Still, Carter stressed, Democrats nationally must "appeal to independents" who are souring on the current administration. Trump's job approval rating, according to Gallup, has dipped to 40 percent, mostly because of declining support among independents. Carter alluded to arguments from self-identified progressives that Democrats will sacrifice votes on the left if they don't embrace the liberal base: "I don't think any Democrat is going to vote against a Democratic nominee," and he insisted that he's not asking the left to sacrifice its goals, only to see that winning elections is necessary to accomplish any of them. There is some historical irony in Carter's analysis. He came to the White House in 1976 from the moderate wing of the Democratic Party, and he clashed with party liberals, drawing a spirited primary challenge in 1980 from Massachusetts Sen. Ted Kennedy. Carter prevailed, but he was wounded, abandoned by Kennedy's most liberal supporters and unable to win over independents who helped deliver a landslide for Republican Ronald Reagan. Carter's latest handicapping comes near the conclusion of a midterm primary season that has seen Democratic primary voters move the party to the left. In some states and districts, that means nominating full-throated advocates of single-payer health care, a $15 minimum wage and abolishing or at least overhauling the federal Immigration and Customs Enforcement agency. In other races, it means nominees who back more cautious moves to the left, such as background checks before certain gun purchases, a "public option" health insurance plan to compete alongside private insurance policies, step raises for the minimum wage and an immigration overhaul that offers legal status to some immigrants in the country illegally. Carter did not delve into those distinctions, instead offering a sweeping condemnation of his latest successor to remind Democrats of the stakes. He denounced the administration's latest environmental policy proposal to make it easier for energy companies to release methane gas that contributes to climate change. He singled out Trump's policy of separating immigrant families at the border, including those seeking asylum. "America is inherently committed to human rights, and I think in the future we will let that prevail," Carter said, "but for the next two years, I can't predict the imprisoned children are going to be any better off unfortunately." Carter has previously criticized Trump for his repeated falsehoods, and he's chided Trump for his hardline support for Israel over Palestinians. Yet Carter has found common ground with Trump on other foreign policy fronts, and did so again Tuesday. While avoiding any mention of the special counsel's investigation into whether Trump's presidential campaign coordinated with Russia in the 2016 U.S. election, Carter said he has engaged for years with Russian President Vladimir Putin concerning the ongoing Syrian civil war. "I have his email address," Carter said, adding that he and Putin share the same Russian river as their favorite spot for salmon fishing. That friendship, Carter said, means when Russia and other nations hold multilateral talks about the Syrian conflict, "Quite often they invite the Carter Center. ... They do not invite the U.S. government." Carter also praised Trump for meeting with North Korean leader Kim Jong Un. Carter repeated his frustrations with the last Democratic president, Barack Obama, for not engaging more directly with the insular Asian nation. Carter said he's not sure Trump has made real progress yet with North Korea, but he endorsed calls for the U.S. to formally declare an end to the Korean War and normalize relations with Pyongyang. "Let them be part of the community of nations," he said. "I think that would be enough in itself to bring an end to the nuclear program in North Korea." ___ Follow Barrow on Twitter at https://twitter.com/BillBarrowAP Claim: Jimmy Carter: To beat Trump, Dems cannot scare off moderates.
answer:
Former President Jimmy Carter sees little hope for the U.S. to change its human rights and environmental policies as long as Donald Trump is in the White House, but he has a warning for his fellow Democrats looking to oust the current administration: Don't go too far to the left.

question:
Paragraph: One new study found that heart attack survivors benefited from a medicine long used to treat gout. Several experimental drugs also showed early promise for interfering with heart-harmful genes without modifying the genes themselves in one case, with treatment just twice a year. The research was featured at an American Heart Association conference ending Monday in Philadelphia. "There's a lot of excitement" about the new gene-targeting medicines, especially because they seem to last so long, said Dr. Karol Watson, of the University of California, Los Angeles. Scientists have been exploring gene therapy altering DNA to attack the root cause of many diseases. The new drugs essentially accomplish the same thing without tampering with genes, said the University of Pennsylvania's Dr. Daniel Rader, who has consulted for some makers of these drugs. The medicines work by silencing or blocking messages that genes give to cells to make proteins that can do harm, such as allowing cholesterol to accumulate. The first few of these "RNA-interference" drugs recently were approved for other conditions, and research is also targeting heart disease. Farthest along is inclisiran, tested in 1,561 people with heart disease from clogged arteries who still had high LDL, the bad form of cholesterol, despite taking standard drugs. They were given a shot of inclisiran or a dummy drug when they joined the study, three months later and then every six months. The drug lowered LDL by 56% without serious side effects. More testing will show whether it also lowers heart attacks and other problems, not just cholesterol. Inclisiran's maker, The Medicines Company, plans to seek federal approval for it later this year. Two other RNA interference drugs aim at a different target triglycerides, another fat in the blood that's elevated in one quarter of Americans. Treatments include very low-fat diets, weight loss, fish oil and drugs, but doctors say more and better therapies are needed. Each RNA interference drug was tested at various doses in 40 people. A single shot lowered triglycerides by 30% to 67%, and the benefit lasted for at least four months. The studies were just intended to show safety; Arrowhead Pharmaceuticals is developing both drugs. Other research found new benefits from older drugs. AstraZeneca's Farxiga, originally developed to treat diabetes, also lowered the risk of heart problems in heart failure patients who did not have diabetes. Among 2,605 of such patients treated for 18 months, about 9% of those on Farxiga had worsening heart failure or heart-related death versus nearly 13% of those not given the drug. That worked out to a 27% lower risk, without extra serious side effects. Surprising benefits also were seen in a Canadian study of the decades-old gout drug. The anti-inflammatory drug colchicine sold as Colcrys, Mitigare and in generic form was tested in 4,745 people who recently had a heart attack. After about two years, colchicine users had a 23% lower risk of suffering a new heart attack, heart-related death, stroke, cardiac arrest or urgent need for an artery-opening procedure compared with a group given dummy pills. The benefit came mostly from preventing strokes and artery-opening procedures, and some heart doctors would rather have seen more difference in heart attacks and deaths. Colchicine is being tested in several other studies, and more evidence is needed before using it routinely to lower heart risks, Dr. L. Kristin Newby of Duke University wrote in a commentary published with the study in the New England Journal of Medicine. Dr. Donald Lloyd-Jones, a Northwestern University cardiologist and program chief for the heart conference, was more supportive. "When you have a safe drug that's easily available, it's going to be hard to hold this one back," he said. ___ Marilynn Marchione can be followed on Twitter at http://twitter.com/MMarchioneAP ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content. Claim: New, old drugs may offer fresh ways to fight heart disease.
answer:
Novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure.